Plexus (NASDAQ:PLXS) Updates Q1 Earnings Guidance

Plexus (NASDAQ:PLXS) issued an update on its first quarter earnings guidance on Wednesday morning. The company provided earnings per share (EPS) guidance of $1.52-$1.67 for the period, compared to the consensus estimate of $1.54. The company issued revenue guidance of $960 million to $1.0 billion, compared to the consensus revenue estimate of $1.03 billion. Plexus also updated its Q1 2025 guidance to 1.520-1.670 EPS.

Plexus Stock Performance

Shares of NASDAQ:PLXS traded up $0.79 on Wednesday, reaching $135.57. The company’s stock had a trading volume of 94,509 shares, compared to its average volume of 126,165. The stock has a market capitalization of $3.69 billion, a P/E ratio of 34.15 and a beta of 0.89. Plexus has a 52-week low of $87.21 and a 52-week high of $139.98. The stock’s 50-day moving average is $129.74 and its two-hundred day moving average is $115.48. The company has a debt-to-equity ratio of 0.07, a current ratio of 1.47 and a quick ratio of 0.64.

Plexus (NASDAQ:PLXS) last issued its quarterly earnings results on Wednesday, July 24th. The technology company reported $1.45 earnings per share for the quarter, topping the consensus estimate of $1.28 by $0.17. The firm had revenue of $960.70 million during the quarter, compared to the consensus estimate of $981.32 million. Plexus had a return on equity of 9.64% and a net margin of 2.82%. The company’s revenue for the quarter was down 6.0% on a year-over-year basis. During the same period last year, the company earned $1.32 earnings per share. As a group, sell-side analysts forecast that Plexus will post 3.74 EPS for the current year.

Wall Street Analysts Forecast Growth

Several research analysts have issued reports on PLXS shares. KeyCorp initiated coverage on Plexus in a research report on Tuesday. They issued a “sector weight” rating for the company. Needham & Company LLC lifted their price target on shares of Plexus from $114.00 to $144.00 and gave the company a “buy” rating in a research report on Friday, July 26th. Finally, Benchmark reaffirmed a “buy” rating and issued a $150.00 price objective on shares of Plexus in a research note on Monday. Three analysts have rated the stock with a hold rating and two have assigned a buy rating to the stock. According to data from MarketBeat, the company has an average rating of “Hold” and an average price target of $125.25.

Insider Buying and Selling at Plexus

In other news, Director Karen Marie Rapp sold 500 shares of the firm’s stock in a transaction that occurred on Friday, August 30th. The shares were sold at an average price of $128.02, for a total transaction of $64,010.00. Following the completion of the transaction, the director now directly owns 9,586 shares of the company’s stock, valued at $1,227,199.72. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. In related news, Director Karen Marie Rapp sold 500 shares of the stock in a transaction on Friday, August 30th. The stock was sold at an average price of $128.02, for a total transaction of $64,010.00. Following the sale, the director now owns 9,586 shares of the company’s stock, valued at $1,227,199.72. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, insider Steven J. Frisch sold 6,565 shares of the business’s stock in a transaction dated Wednesday, July 31st. The shares were sold at an average price of $128.11, for a total transaction of $841,042.15. Following the completion of the transaction, the insider now directly owns 36,118 shares of the company’s stock, valued at $4,627,076.98. The trade was a 0.00 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 20,113 shares of company stock valued at $2,541,394 over the last quarter. Corporate insiders own 2.39% of the company’s stock.

About Plexus

Plexus Corp. provides electronic manufacturing services in the United States and internationally. It offers design, develop, supply chain, new product introduction, and manufacturing solutions, as well as sustaining services to companies in the healthcare/life sciences, industrial/commercial, aerospace/defense, and communications market sectors.